CFO for a series of UK acquisitions by Mediq Group under the ownership of leading private equity investor Advent International

Looking for a new challenging opportunity ideally in rapid growth or turnaround

UKIre's fastest growing biotech with sales increasing from $60m to $360m from 2010 to 2019.Building and leading a high performing team of 34 covering Finance, Operations & Customer Service.• Increased sales six-fold in 9 years through existing and new treatments via focused strategy to gain market access and grow market share in competitive markets.• Built Finance & Operations functions from scratch combining disparate in-house support teams with high performers from within the industry to support & drive business expansion.• Introduced innovative technologies including Concur, digital invoice scanning, automatic invoice/PO matching, automating additional processes where possible.• Implemented strategic planning, forecasting and budgeting processes increasing accountability and visibility together with long term strategic plan.• Developed customer service offering & relationships within the NHS & other stakeholders. • Member of industry Finance Directors’ Steering Committee & NHS pricing negotiation team • Integrated UK acquisition with trebling of growth in first year.• Launched Team Development Programme with multiple secondments and succession plan• Led $240m Oncology Division as Business Unit Director 2017/18, re-aligning marketing & field functions, preparing for new product launches and accelerating YOY growth to 20%.

• Recruited and developed a high-calibre Finance team to support strong business growth from $60m sales to $170m in 3 years, implementing strong controls and automation of manual processes• Designed and implemented monthly reporting leadership information and action pack generating proposals for business optimisation to maximise growth potential• Introduced Governance & Compliance Forum to ensure adherence with local and international industry policies and codes of conduct• Introduced and coordinated robust quarterly forecasting process engaging the whole business resulting in top-tier forecasting accuracy

Group FD of €450m t/o international gaming group. Privately owned with 1700 retail outlets in 8 countries. UK based Group Head Office.• Restructured Group tax organisation driving extra £1.6m (15%) EBIT in first year.• Secured bank lending facility previously not achieved or deemed possible by business.• Rationalised Finance teams, introducing group tax treasury function and fx hedging.• Prepared and launched development plan with MDs improving group EBIT by 55% (2010).• Introduced robust group monthly reporting, cash/currency forecasting and internal controls.• Managed shareholders’/joint venture partners’ interests securing new venture funding.

Turning around the Co-operative's £1bn travel group from loss to profit in 18 months and integrating United's various travel divisions.

UK's largest funeral business with 600 branches, £220m t/o. Also GM responsibility for manufacturing and masonry divisions.